APA (7th ed.) Citation

Stone, R. M., Fischer, T., Paquette, R., Schiller, G., Schiffer, C. A., Ehninger, G., . . . Giles, F. (2012). Phase IB study of the FLT3 kinase inhibitor midostaurin with chemotherapy in younger newly diagnosed adult patients with acute myeloid leukemia. Leukemia (08876924), 26(9), 2061. https://doi.org/10.1038/leu.2012.115

Chicago Style (17th ed.) Citation

Stone, R M., et al. "Phase IB Study of the FLT3 Kinase Inhibitor Midostaurin with Chemotherapy in Younger Newly Diagnosed Adult Patients with Acute Myeloid Leukemia." Leukemia (08876924) 26, no. 9 (2012): 2061. https://doi.org/10.1038/leu.2012.115.

MLA (9th ed.) Citation

Stone, R M., et al. "Phase IB Study of the FLT3 Kinase Inhibitor Midostaurin with Chemotherapy in Younger Newly Diagnosed Adult Patients with Acute Myeloid Leukemia." Leukemia (08876924), vol. 26, no. 9, 2012, p. 2061, https://doi.org/10.1038/leu.2012.115.